Get the Daily Brief
Latest Biotech News
Breakthroughs in Type 1 and Type 2 Diabetes Treatments
Vertex Pharmaceuticals’ cell therapy zimislecel showed promising Phase 1/2 results in type 1 diabetes, with most patients achieving insulin independence and controlled blood glucose one year...
Precision Oncology Advances with Genomic Chemotherapy Resistance Biomarkers
An international collaboration led by the Spanish National Cancer Research Centre and partners at Cambridge and Tailor Bio has developed a novel genomic test leveraging chromosomal instability...
AI and Robotics Transform Airway Management and Biomechanics Prediction
Medical technology innovations are advancing airway management with robotic intubation systems and AI-powered anatomical recognition, promising improvements in accuracy and patient safety during...
Innovations in Neuroscience: Brain Mapping and Epilepsy Management
Washington University researchers developed Cirrus, an AI-driven resting state fMRI software approved by the FDA, that accelerates neurosurgical brain mapping by producing detailed functional...
Cancer Therapy Advances: Bispecifics, Antibody-Drug Conjugates, and CAR-T Enhancements
Recent developments in oncology include a phase 3 trial where Roche’s combination of bispecific antibody Lunsumio and antibody-drug conjugate Polivy significantly improved progression-free...
Cidara's Flu Prevention Treatment Surges on Promising Trial Data
Cidara Therapeutics reported positive Phase 2b results for its long-acting antiviral biologic CD-388, designed to prevent seasonal influenza in healthy adults aged 18 to 64. The single-dose...
FDA Leadership Changes Stir Biopharma Industry Concerns
The FDA is undergoing significant leadership turnover with Jacqueline Corrigan-Curay, acting head of the Center for Drug Evaluation and Research (CDER), announcing her retirement in July. This...
Illumina Acquires SomaLogic to Expand Proteomics and Multiomics
Illumina has agreed to acquire SomaLogic from Standard BioTools for up to $425 million. The acquisition expands Illumina’s capabilities in proteomics and enhances its multiomics strategy by...
Novel Cancer Therapy Combines Bispecific and ADC Agents to Improve Survival
Roche demonstrated a phase 3 trial success combining the CD20xCD3 bispecific antibody Lunsumio with the antibody-drug conjugate Polivy to treat large B-cell lymphoma (LBCL) patients ineligible for...
Breakthrough AI Biometric Monitoring in Parkinson’s and Biomechanics
Emerging studies leverage AI to enhance medical diagnostics and predictive modeling. One demonstrates that deep learning models incorporating knee alignment significantly improve predictions of...
Advances in Neuroscience: Neural Recording and Brain Function Insights
New high-density neural recording technologies enable brain-wide, real-time monitoring of tens of thousands of neurons in awake primates, providing unprecedented resolution of neural dynamics...
Novel Therapies and Diagnostics in Diabetes and Obesity Management
Recent data highlight progress in diabetes and obesity treatments. Vertex Pharmaceuticals’ cell therapy zimislecel shows promising Phase 1/2 results enabling insulin independence in type 1...
Innovations in Molecular Imaging for Cancer Diagnosis and Treatment Prediction
Cutting-edge molecular imaging agents show promise in improving cancer diagnostics and therapeutic decision-making. Novel immunoPET tracers targeting PD-L1 (^18F-AlF-NOTA-PCP2) and glypican-3...
Climate and Environmental Impacts on Agriculture and Health
Recent studies explore the intersection of climate change, agricultural sustainability, and health. Research on Xinjiang cotton assesses future water footprint variations under climate scenarios,...
Cidara’s CD-388 Flu Drug Shakes Market with Phase IIb Win
San Diego-based biotechnology firm Cidara Therapeutics reported highly positive Phase IIb results for its long-acting antiviral biologic, CD-388, showing strong prevention efficacy against...
Illumina to Acquire SomaLogic, Expanding Proteomics Portfolio
Illumina is set to acquire SomaLogic from Standard BioTools in a deal valued at up to $425 million, including an upfront payment and performance-based milestones and royalties. SomaLogic’s...
FDA Leadership Exodus Continues Amid Regulatory Shifts
The U.S. Food and Drug Administration is experiencing significant leadership turnover as Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and Research (CDER), announced...
Breakthrough in Cancer Chemotherapy Resistance Prediction
Researchers from the Spanish National Cancer Research Centre, in collaboration with the University of Cambridge and Tailor Bio, have developed a novel genomic test capable of predicting...
Novel Oral Drug Candidate Challenges GLP-1 Therapies for Diabetes and Obesity
A promising new oral β2 adrenergic receptor agonist exhibiting GRK-biased signaling emerges as a potential alternative to injectable GLP-1 receptor agonists in treating type 2 diabetes and...
Advances in CAR-T Cell Therapy Targeting Tumor Microenvironment
Recent innovations in chimeric antigen receptor T-cell (CAR-T) therapy are addressing critical limitations in lymphoma treatment by engineering cells capable of overcoming tumor microenvironment...